Proceedings, Debates of the U.S. Congress
February 18, 2020
116th Congress, 2nd Session
Issue: Vol. 166, No. 33 — Daily Edition
Entire Issue (PDF)
Constitutional Authority Statement for H.R. 5927; Congressional Record Vol. 166, No. 33
(House of Representatives - February 18, 2020)
Text available as:
Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.
[Page H1164] From the Congressional Record Online through the Government Publishing Office [www.gpo.gov] By Mr. POSEY: H.R. 5927. Congress has the power to enact this legislation pursuant to the following: Article 1 Section 8 of the Constitution declares that Congress has the power ``To regulate commerce with foreign nations, and among the several states, and with the Indian tribes;'' Article 2 Section 2 allows Congress to create other executive officers. Finally, in Article 1, Section 8 clarifies that Congress has the right to make ``all Laws which shall be necessary and proper for carrying into Execution the foregoing Powers.'' It is in keeping with the power invested in Congress under these articles to direct the Secretary of Health and Human Services (HHS) to study our dependence on Chinese pharmaceuticals; direct HHS to provide recommendations for weaning the American people off this dangerous dependence; and authorize the U.S. Food and Drug Administration to issue black-box warnings informing consumers of any risk they are taking when using pharmaceuticals from countries with systemic issues of supervision.